Hospira 4Q Revenues: $706.5 million (+9%) 4Q Earnings: $47.4 million (+78%) FY Revenues: $2.7 billion (+2.4%) FY Earnings: $237.7 (flat) Comments: In the quarter, net sales to Abbott Laboratories were $38 million, up 1%, and for the year were $160.8 million, down 5%. Injectable pharmaceutical contract manufacturing revenue was $43.4 million, up 32% for the quarter, and was $183.3 million for the year, up 2.5%. In the quarter the company completed the acquisition of BresaGe...